Physician profile
Amar Siddique
NPI 1659359404
$2,372.03
in general payments reported to CMS, 2019-2025
20 companies · $1,225 in 2025
The $1,225 reported for 2025 was more than what 98% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $43.19 · 2021: $397 · 2022: $105 · 2023: $273 · 2024: $83.15 · 2025: $1,225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $974 · Food and Beverage: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $973.64 |
| Food and Beverage | $607.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainsway USA INC | $973.64 | 2025 | Deep Tms System |
| Supernus Pharmaceuticals, INC. | $263.09 | 2021-2025 | Qelbree |
| Cranial Technologies, INC | $208.33 | 2020-2024 | Doc Band |
| Phadia US INC. | $153.53 | 2021-2025 | Immunocap |
| Sanofi Pasteur INC. | $138.52 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $110.17 | 2023 | Farxiga |
| Jazz Pharmaceuticals INC. | $100.00 | 2019 | |
| Merck Sharp & Dohme LLC | $83.95 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Sobi, INC | $60.54 | 2019 | |
| Ironshore Pharmaceuticals INC. | $45.85 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $33.51 | 2021 | |
| Pfizer INC. | $30.84 | 2023 | |
| Ars Pharmaceuticals Operations, INC. | $29.59 | 2025 | Neffy |
| Seqirus USA INC | $27.39 | 2024-2025 | Flucelvax |
| Lnhc, INC | $23.45 | 2025 | Zelsuvmi |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $23.18 | 2019 | |
| Corium, LLC | $21.90 | 2023 | Azstarys |
| Sanofi-Aventis U.S. LLC | $17.94 | 2024 | |
| Nestle Healthcare Nutrition INC. | $13.61 | 2023 | |
| Verrica Pharmaceuticals INC. | $13.00 | 2023 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amar Siddique listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.